StableX CEO granted 220,513 options at $6.25 strike (Form 4)
StableX Technologies, Inc. (SBLX) reported an insider equity award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
StableX Technologies, Inc. (SBLX) reported an insider equity award. CEO and Director Joshua Silverman filed a Form 4 disclosing an employee stock option grant to purchase 220,513 shares of common stock at an exercise price of $6.25 per share on 10/31/2025. The filing lists the option grant price as $0.
Vesting terms: 75% vested on the grant date; the remaining 25% is scheduled to vest on December 31, 2025, contingent on continued service. Following the transaction, Silverman directly beneficially owns 220,513 derivative securities.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy | 220,513 | $0.00 | $0.00 |
Footnotes (1)
- F1. The stock options vest as follows: (i) 75% vested upon the date of grant; and (ii) 25% will vest on December 31, 2025, provided that the Reporting Person remains employed by or providing services to the Issuer on the applicable vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did SBLX report on this Form 4?
What are the vesting terms of the SBLX option grant?
How many derivative securities does the reporting person own after the transaction?
What is the exercise price of the options reported by SBLX?
Who is the reporting person on the SBLX Form 4?
When is the earliest transaction date reported?
AI-generated analysis. How Rhea-AI works. Not financial advice.